-
16. SYNTHESIS OF SILVER NANOPARTICLES WITH ANTIBACTERIAL ACTIVITY USING THE LICHEN PARMOTREMA PRAESOREDIOSUM
INTERNATIONAL JOURNAL OF NANOMEDICINE
2013 SCI CO-AUTHOR -
17. SYNTHESIS, ANTIBACTERIAL ACTIVITY AND CYTOTOXICITY OF NEW FUSED PYRAZOLO[1,5-A]PYRIMIDINE AND PYRAZOLO[5,1-C][1,2,4]TRIAZINE DERIVATIVES FROM NEW 5-AMINOPYRAZOLES
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2013 WOS CO-AUTHOR -
18. SCREENING FOR ANTIYEAST ACTIVITIES FROM SELECTED MEDICINAL PLANTS
JOURNAL OF TROPICAL FOREST SCIENCE
2005 SCOPUS CO-AUTHOR -
19. ANTIBACTERIAL AND ANTIFUNGAL EFFICACY OF CURCUMA DOMESTICA
MALAYSIAN JOURNAL OF MEDICAL SCIENCES
1999 SCOPUS CO-AUTHOR
ACADEMIC QUALIFICATIONS
- PhD in Molecular Bacteriology (2014)
- Master in Biology (2003)
- B.Sc. in Biomedical Sciences (1999)
EXPERTISE
- Clinical Laboratory Microbiology
- Natural Product Research
- Bacteriology
PROF. MADYA DR. SITI NOOR ADNALIZAWATI BINTI ADNANPENSYARAH UNIVERSITI DS14 Faculty Fakulti Pergigian Biography A lecturer from Fakulti Pergigian. Holds a Phd in Molecular Bacteriology. Usim Expert: https://expert.usim.edu.my/adnaliza Phone: 603-42892400 E-mail: adnaliza@usim.edu.my |
RESEARCHER
ID
|
-
1. THE SECONDARY METABOLITES OF STINGLESS BEE BEEHIVE AND ITS ANTIMICROBIAL PROPERTY AGAINST COMMON ORAL PATHOGENS
2024 GERAN PENYELIDIKAN PUSAT TANGGUNGJAWAB (PTJ) ON GOING MAIN RESEARCHER -
2. MECHANISM STUDIES AND BIOLOGICAL ACTIVITIES OF ALPINIA CONCHIGERA AND 1?S-1?-ACETOXYCHAVICOL ACETATE AGAINST CLINICAL ORAL OPPORTUNISTIC PATHOGENS
2021 GERAN KPT ON GOING CO-RESEARCHER -
3. TRANSCRIPTOME ANALYSIS OF ORAL PATHOGENS IN RESPONSE TO TANNIN
2018 GERAN PENYELIDIKAN USIM COMPLETED MAIN RESEARCHER -
4. THE PREVALENCE OF STAPHYLOCOCCUS AUREUS IN THE ORAL CAVITIES OF HEALTHY ADULTS
2018 PENYELIDIKAN TANPA BIAYA COMPLETED CO-RESEARCHER -
5. THE ANTIMICROBIAL ACTIVITY OF TANNIN FFROM PHYLLANTUS COLUMNARIS STEM BARK AGAINTS C. ALBIANS, P. GINGIVALIS AND S. MUTANS : AN IN VITRO PATHOGENS.
2017 GERAN PENYELIDIKAN HEADSTART PROGRAM COMPLETED CO-RESEARCHER
Completed: 5 (71%)
Ongoing: 2 (29%)